Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade PMID 42321916
View analysis →A grade PMID 42372741
View analysis →A grade PMID 42216567
View analysis →A grade PMID 41916649
View analysis →A grade PMID 42382416
View analysis →A grade PMID 42150584
View analysis →A grade PMID 41756844
View analysis →A grade PMID 42362103
View analysis →A grade PMID 42101908
View analysis →A grade PMID 42248607
View analysis →A grade PMID 41667193
View analysis →A grade PMID 42260111
View analysis →This retrospective analysis of Minas Gerais administrative data reports 3,883 hospitalizations and 79 pediatric bone and articular-cartilage cancer deaths during 2015–2024, with stable mortality despite declining hospitalizations and regional and demographic differences.
The record provides descriptive evidence of persistent mortality and regional variation; it supports the untested inference that earlier detection, referral, and more equitable access to specialized oncology services could improve outcomes, but it evaluates no specific intervention or therapy.
This case reports clinically, endoscopically, and histologically diagnosed juvenile polyposis syndrome with colonic and gastric polyposis in a 14-year-old with repaired Tetralogy of Fallot and Fontan-type physiology, emphasizing cancer-risk surveillance and multidisciplinary care.
The record supports early recognition, endoscopic assessment, and surveillance for juvenile polyposis in symptomatic children with complex congenital heart disease; it is only an inference—not demonstrated here—that heightened diagnostic vigilance could reduce delayed cancer-risk management or improve longer-term outcomes.
This case report describes a 54-year-old woman with atypical adult-onset hyperphosphatemic familial tumoral calcinosis, biochemical evidence of disordered phosphate handling, and a novel homozygous deletion of GALNT3 exons 8–9, with partial symptomatic improvement after multimodal treatment.
The reported partial improvement suggests that phosphate-lowering and anti-inflammatory management may reduce symptoms in GALNT3-associated HFTC, but this is an inference from a single case and does not establish efficacy, safety, or relevance to pediatric oncology.
This case report describes an antenatally detected, persistent abdominal cyst in a term female neonate that was non-specific on imaging, found surgically to arise from the right adnexa, and diagnosed histopathologically as ovarian serous cystadenoma.
The reported evidence shows that a rare benign ovarian neoplasm can mimic other neonatal abdominal cysts and be identified through surgical exploration and histopathology; it is reasonable but unproven to infer that including serous cystadenoma in the differential diagnosis could improve operative planning and selection of persistent or large lesions for timely intervention.
This single-patient report describes Hirschsprung’s disease diagnosed in a 61-year-old with a synchronous rectosigmoid neoplasm, managed by combined abdominal–transanal resection, lymphadenectomy, coloanal anastomosis, protective ileostomy, and adjuvant chemotherapy, with no residual disease reported on post-treatment CT.
The case provides evidence that multidisciplinary adult and pediatric colorectal expertise can facilitate definitive management of unusually late-presenting Hirschsprung’s disease with synchronous colorectal carcinoma; any hypothesis that chronic intestinal stasis promotes malignancy, or that this operative strategy improves outcomes over alternatives, remains untested inference.
This single-center retrospective study of 133 patients with Klinefelter syndrome found that higher-grade sex chromosome aneuploidies were associated with earlier diagnosis and higher rates of congenital anomalies, dysmorphic features, and neurodevelopmental impairment than classical 47,XXY.
The evidence supports karyotype-informed recognition and surveillance of Klinefelter-associated comorbidities; it only indirectly suggests that earlier pediatric identification could improve management, and the record provides no evidence for an oncology treatment, cancer-screening strategy, or improved clinical outcomes.
In a cross-sectional analysis of 45,307 women in Brazil's 2019 National Health Survey, non-heterosexual women were less likely than heterosexual women to report a Papanicolaou test within the previous three years.
The evidence identifies a cervical-cancer screening disparity rather than a treatment effect; it supports the inference that targeted, inclusive screening outreach might improve timely screening among homosexual and bisexual women, but no intervention or cancer outcome was tested.
This report describes a 12-year-old girl with prior Wilms tumor who developed orbital embryonal rhabdomyosarcoma and had a likely pathogenic TRIP13 null variant suggesting mosaic variegated aneuploidy syndrome 3.
The case provides evidence that recognizing a possible TRIP13-associated cancer-predisposition syndrome can prompt genetic counseling and systemic surveillance; it is an inference, not demonstrated here, that earlier syndrome identification could improve tumor surveillance or treatment planning.
This article reviews pediatric renal and adrenal MRI, including protocol optimization, imaging features of congenital and neoplastic conditions, and the potential of diffusion-weighted and dynamic contrast-enhanced MRI to improve diagnosis and guide care.
The supplied record supports advanced MRI as a diagnostic and care-guidance tool; it is reasonable but unproven to hypothesize that functional imaging biomarkers could improve tumor characterization or treatment selection in pediatric Wilms tumor or neuroblastoma, because no therapeutic intervention, comparative outcome, or validation data are reported.
In a retrospective series of six pathology-confirmed pediatric abdominal or retroperitoneal lipoblastomas, ultrasound commonly showed solitary, large, well-defined, predominantly hyperechoic masses with cord-like fat-like echogenic areas, and prospectively suggested lipoblastoma in five cases.
Evidence: this small descriptive series identifies ultrasound features that may support recognition and follow-up of pediatric abdominal or retroperitoneal lipoblastoma; inference: if validated in larger comparative cohorts, these features could improve diagnostic triage and surveillance, but the record provides no evidence of treatment selection, reduced toxicity, or improved outcomes.
This report describes two adolescent patients with suspected Ewing sarcoma whose overlapping clinical, histopathologic, and immunohistochemical findings created diagnostic ambiguity, while confirmatory EWSR1 rearrangement testing was unavailable or not completed.
The cases support the diagnostic observation that morphology and immunohistochemistry may be insufficient for distinguishing Ewing sarcoma from related small round cell tumors; it is plausible, but not demonstrated here, that accessible molecular testing could improve diagnostic classification and treatment selection.
This case report describes a 10-year-old boy with a primary dura-based intracranial myxoma presenting with seizure who remained seizure-free at 18 months after gross total resection and temporary levetiracetam treatment.
The reported case supports complete surgical resection, with exclusion of a cardiac primary, as a feasible management approach for localized pediatric primary intracranial myxoma; inference beyond this single case—such as durable disease control or superiority over other strategies—requires additional evidence.
